Prognostic value of biochemical markers of brain damage and oxidative stress in post-surgical aneurysmal subarachnoid hemorrhage patients

Brain Research Bulletin

Volumn 81, Issue 1, 2010, Pages 173-177

  Kaneda, Kotaro ^a   Fujita, Motoki ^a   Yamashita, Susumu ^b   Kaneko, Tadashi ^a   Kawamura, Yoshikatsu ^a   Izumi, Tomonori ^a   Tsuruta, Ryosuke ^a   Kasaoka, Shunji ^a   Maekawa, Tsuyoshi ^a  

^a YAMAGUCHI UNIVERSITY HOSPITAL   (Japan)

^b KAGAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Glial fibrillary acidic protein; Malondialdehyde; Neuron specific enolase; S100B; Subarachnoid hemorrhage

Indexed keywords

BIOCHEMICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN; MALONALDEHYDE; NEURON SPECIFIC ENOLASE; PROTEIN S100B;

ADULT; ANEURYSM SURGERY; AREA UNDER THE CURVE; ARTICLE; BRAIN ARTERY ANEURYSM; BRAIN DAMAGE; CEREBROSPINAL FLUID DRAINAGE; CLINICAL PRACTICE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLASGOW OUTCOME SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY; SUBARACHNOID HEMORRHAGE;

ANALYSIS OF VARIANCE; AREA UNDER CURVE; BRAIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INTRACRANIAL ANEURYSM; MALE; MALONDIALDEHYDE; MIDDLE AGED; NERVE GROWTH FACTORS; OXIDATIVE STRESS; PHOSPHOPYRUVATE HYDRATASE; PROGNOSIS; ROC CURVE; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPECTROPHOTOMETRY; SUBARACHNOID HEMORRHAGE; TIME FACTORS;

EID: 71349083305     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2009.10.020     Document Type: Article

References (30)

1. Aki H.S., Fujita M., Yamashita S., Fujimoto K., Kumagai K., Tsuruta R., Kasaoka S., Aoki T., Nanba M., Murata H., Yuasa M., Maruyama I., and Maekawa T. Elevation of jugular venous superoxide anion radical is associated with early inflammation, oxidative stress, and endothelial injury in forebrain ischemia-reperfusion rats. Brain. Res. 1292 (2009) 180-190
2. Anderson R.E., Hansson L.O., Nilsson O., Dijlai-Merzoug R., and Settergren G. High serum S100B levels for trauma patients without head injuries. Neurosurgy 48 (2001) 1255-1258 (discussion, 1258-1260)
3. Ausman J.I., Diaz F.G., Malik G.M., Andrews B.T., McCormick P.W., and Balakrishnan G. Management of cerebral aneurysms: further facts and additional myths. Surg. Neurol. 32 (1989) 21-35
4. Bisoffi G., Mazzi M.A., and Dunn G. Evaluating screening questionnaires using Receiver Operating Characteristics (ROC) curves from two-phase (double) samples. Int. J. Methods Psychiatr. Res. 9 (2000) 121-133
5. Burger R.M., Berkowitz A.R., Peisach J., and Horwitz S.B. Origin of malondialdehyde from DNA degraded by Fe(II) x bleomycin. J. Biol. Chem. 255 (1980) 11832-11838
6. Cheeseman K.H., Emery S., Maddix S.P., Slater T.F., Burton G.W., and Ingold K.U. Studies on lipid peroxidation in normal and tumour tissues. The Yoshida rat liver tumour. Biochem. J. 250 (1988) 247-252
7. Claassen J., Carhuapoma J.R., Kreiter K.T., Du E.Y., Connolly E.S., and Mayer S.A. Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke 33 (2002) 1225-1232
8. Cunningham R.T., Morrow J.I., Johnston C.F., and Buchanan K.D. Serum neurone-specific enolase concentrations in patients with neurological disorders. Clin. Chim. Acta 230 2 (1994) 117-124
9. Dugan L.L., and Kim-Han J.S. Astrocyte mitochondria in in vitro models of ischemia. J. Bioenerg. Biomembr. 36 4 (2004) 317-321
10. Edner G., Kagstom E., and Wellstedt L. Total overall management and surgical outcome after subarachnoid hemorrhage in a defined population. Br. J. Neurosurg. 6 (1992) 409-420
11. Germanson T.P., Lanzino G., Kongable G.L., Torner J.C., and Kassell N.F. Risk classification after aneurysmal subarachnoid hemorrhage. Surg. Neurol. 49 (1998) 155-163
12. Gutteridge J.M.C. Thiobarbituric acid-reactivity following iron-dependent free-radicals damage to amino acids and carbohydrates. FEBS Lett. 128 (1981) 343-346
13. Haimoto H., Takahashi Y., Koshikawa T., Nagura H., and Kato K. Immunohistochemical localization of gamma-enolase in normal human tissues other than nervous and neuroendocrine tissues. Lab. Invest. 52 3 (1985) 257-263
14. Hardemark H.G., Almqvist O., Johansson T., Pahlman S., and Persson L. S-100 protein in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: relation to functional outcome, late CT and SPECT changes, and signs of higher cortical dysfunction. Acta Neurochirurgica (Wien) 99 (1989) 135-144
15. Hauschild A., Engel G., Brenner W., Gläser R., Mönig H., Henze E., and Christophers E. Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapy. Br. J. Dermatol. 140 (1999) 1065-1071
16. Haydon P.G., and Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol. Rev. 86 3 (2006) 1009-1031
17. Hutchinson P.J., Power D.M., Tripathi P., and Kirkpatrick P.J. Outcome from poor grade aneurysmal subarachnoid haemorrhage-which poor grade subarachnoid haemorrhage patients benefit from aneurysm clipping?. Br. J. Neurosurg. 14 (2000) 105-109
18. Jennett B., and Bond M. Assessment of outcome after severe brain damage. Lancet 1 1 (1975) 480-484
19. Kassel N.F., Torner J.C., Haley E.C., Jane J.A., Adams H.P., and Kongable G.L. The international cooperative study on the timing of aneurysm surgery. Part 1: overall management results. J. Neurosurg. 73 (1990) 18-36
20. Kaynar M.Y., Tanriverdi T., Kemerdere R., Atukeren P., and Gumustas K. Cerebrospinal fluid superoxide dismutase and serum malondialdehyde levels in patients with aneurysmal subarachnoid hemorrhage: preliminary results. Neurol. Res. 2 5 (2005) 562-567
21. Lagares A., Gomez P.A., Lobato R.D., Alen J.F., Alday R., and Campollo J. Prognostic factors on hospital admission after spontaneous subarachnoid haemorrhage. Acta Neurochirurgica (Wien) 143 (2001) 665-672
22. Oertel M., Schumacher U., McArthur D.L., Kästner S., and Böker D.K. S-100B and NSE: markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome. J. Clin. Neurosci. 13 8 (2006) 834-840
23. Petzold A. CSF biomarkers for improved prognostic accuracy in acute CNS disease. Neurol. Res. 29 7 (2007) 691-708
24. Petzold A., Keir G., Kerr M., Kay A., Kitchen N., Smith M., and Thompson E.J. Early identification of secondary brain damage in subarachnoid hemorrhage: a role for glial fibrillary acidic protein. J. Neurotrauma 23 7 (2006) 1179-1184
25. Petzold A., Keir G., Lim D., Smith M., and Thompson E.J. Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern. Brain Res. Bull. 61 3 (2003) 281-285
26. Ramont L., Thoannes H., Volondat A., Chastang F., Millet M.C., and Maquart F.X. Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice. Clin. Chem. Lab. 43 11 (2005) 1215-1217
27. Schievink W.I. Intracranial aneurysms. N. Engl. J. Med. 336 (1997) 28-40
28. Sehba F.A., Schwartz A.Y., Chereshnev I., and Bederson J.B. Acute decrease in cerebral nitric oxide levels after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 20 3 (2000) 604-611
29. Suzuki F., Kato K., and Nakajima T. Hormonal regulation of adipose S-100 protein release. J. Neurochem. 43 (1984) 1336-1341
30. Vos P.E., van Gils M., Beems T., Zimmerman C., and Verbeek M.M. Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity. Eur. J. Neurol. 13 6 (2006) 632-638